Wellington Management Group
FATE icon

Wellington Management Group’s Fate Therapeutics FATE Stock Holding History

Wellington Management Group’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$664K Buy
+245,814
New +$455K ﹤0.01% 1803
2024
Q3 		– Sell
-75,161
Closed -$247K – 1950
2024
Q2 		$247K Buy
75,161
+30,976
+70% +$136K ﹤0.01% 1845
2024
Q1 		$324K Buy
+44,185
New +$273K ﹤0.01% 1846
2022
Q4 		– Sell
-568,382
Closed -$12.7M – 2031
2022
Q3 		$12.7M Sell
568,382
-22,297
-4% -$644K ﹤0.01% 1035
2022
Q2 		$14.6M Sell
590,679
-140,446
-19% -$3.88M ﹤0.01% 1027
2022
Q1 		$28.3M Buy
731,125
+31,373
+4% +$1.21M ﹤0.01% 936
2021
Q4 		$40.9M Buy
699,752
+89,212
+15% +$5.06M 0.01% 891
2021
Q3 		$36.2M Buy
610,540
+359,535
+143% +$28.2M 0.01% 918
2021
Q2 		$21.8M Buy
251,005
+70,557
+39% +$5.69M ﹤0.01% 1076
2021
Q1 		$14.9M Sell
180,448
-13,797
-7% -$1.32M ﹤0.01% 1139
2020
Q4 		$17.7M Buy
+194,245
New +$12.1M ﹤0.01% 1066
2020
Q1 		– Sell
-39,006
Closed -$764K – 1957
2019
Q4 		$764K Buy
+39,006
New +$619K ﹤0.01% 1771
2016
Q1 		– Sell
-1,306,569
Closed -$4.4M – 2154
2015
Q4 		$4.4M Sell
1,306,569
-155,953
-11% -$655K ﹤0.01% 1402
2015
Q3 		$7.8M Sell
1,462,522
-37,126
-2% -$254K ﹤0.01% 1245
2015
Q2 		$9.7M Buy
1,499,648
+41,950
+3% +$251K ﹤0.01% 1235
2015
Q1 		$7.13M Buy
1,457,698
+36,770
+3% +$182K ﹤0.01% 1347
2014
Q4 		$7.15M Buy
1,420,928
+1,953
+0.1% +$8.62K ﹤0.01% 1334
2014
Q3 		$7.29M Buy
1,418,975
+224,965
+19% +$1.3M ﹤0.01% 1331
2014
Q2 		$7.53M Buy
1,194,010
+72,830
+6% +$513K ﹤0.01% 1332
2014
Q1 		$10.9M Sell
1,121,180
-76,020
-6% -$587K ﹤0.01% 1215
2013
Q4 		$7.52M Buy
+1,197,200
New +$7.54M ﹤0.01% 1338

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Wellington Management Group's FATE Position: Q2 2026 in Review

Wellington Management Group opened a new position in Fate Therapeutics (FATE) in Q2 2026: 245,814 shares worth $664K. The stake represents ﹤0.01% of the portfolio and ranks #1803 among its holdings. This is a return to the name: Wellington Management Group previously reported a position in FATE as recently as Q2 2024.

Wellington Management Group first reported a position in FATE in Q4 2013 and has held it in 21 quarters since. The position peaked at $40.9M in Q4 2021. 155 funds tracked by Wall St. Rank hold FATE as of Q2 2026.

  • Wellington Management Group held 245,814 shares of Fate Therapeutics worth $664K as of Q2 2026.
  • Fate Therapeutics was a new Wellington Management Group position in Q2 2026.
  • Fate Therapeutics made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1803 holding.
  • Wellington Management Group first reported a position in Fate Therapeutics in Q4 2013 and has held it in 21 quarters since.
  • Wellington Management Group's Fate Therapeutics position peaked at $40.9M in Q4 2021.
  • 155 funds tracked by Wall St. Rank held Fate Therapeutics as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.